Statin derivatives as therapeutic agents for castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Statin derivatives as therapeutic agents for castration-resistant prostate cancer

Published:2016-12 Issue:1 Volume:383 Page:94-105
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ingersoll Matthew A.,Miller Dannah R.,Martinez October,Wakefield C. Brent,Hsieh Kuan-Chan,Simha M. Vijaya,Kao Chai-Lin,Chen Hui-Ting,Batra Surinder K.,Lin Ming-Fong

Funder

National Institute of Health

Department of Defense

University of Nebraska Medical Center

Graduate Studies Fellowship

MOST

KMU

NSYSUKMU

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2014

2. Guidelines for the management of castrate-resistant prostate cancer;Saad;Can. Urol. Assoc. J.,2010

3. New strategies for medical management of castration-resistant prostate cancer;Asmane;Oncology,2011

4. Castration-resistant prostate cancer: AUA Guideline;Cookson;J. Urol.,2013

5. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration;Smalet;J. Clin. Oncol.,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Resistance in Prostate Cancer Therapy Using a DZ-Simvastatin Conjugate;Molecular Pharmaceutics;2024-01-17

2. Resistance of prostate cancer to topoisomerase inhibitors;Therapy Resistance in Prostate Cancer;2024

3. Statin use and outcomes of oncological treatment for castration-resistant prostate cancer;Scientific Reports;2023-11-01

4. Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression;Free Radical Biology and Medicine;2022-11

5. Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8;Biochemical and Biophysical Research Communications;2022-01